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A B S T R A C T
Several Lippia species have been used in folk medicine mainly for gastrointestinal and 
respiratory diseases. Their biological properties have been partially associated to the 
terpenoids found in their essential oils. According to the World Health Organization, cancer 
is the leading cause of death worldwide and is described as a complex group of diseases with 
several hallmarks. One of its acceptable defining features is the cell proliferation beyond their 
boundaries forming the tumors. Importantly, some drugs currently available were discovered 
by the investigation of plant secondary metabolites. Thus, this study aimed to evaluate in 
vitro cytotoxic effect of the essential oils extracted from five Lippia species against tumor 
cell lines. The results indicated that mouse colon carcinoma CT26.WT cell line viability was 
significantly reduced showing an IC50 of 19.05, 30.20 and 36.30 μg/ml when treated with the 
essential oils of L. sidoides, L. salviifolia and L. rotundifolia, respectively. Human lung carcinoma 
A549 cell line also had a compromised viability to the action of L. alba carvone chemotype 
essential oil. The tested essential oils did not compromise viability of the normal cell line 
CHO. These finds suggest that the studied Lippia essential oils might be good candidates for 
further in-depth studies.
© 2013 Brazilian Society of Pharmacognosy. Published by 
Elsevier Editora Ltda. 
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Introduction
It has been reported that incidence and mortality rates for 
most cancers are decreasing in the United States and many 
other western countries, however they are increasing in several 
less developed and economically transitioning countries. The 
proportion of new cancer cases diagnosed in less developed 
countries is projected to increase from about 56% of the total 
world in 2008 to more than 60% in 2030 (Jemal et al., 2010). 
Worldwide, lung cancer is the most common in term of cases 
and deaths. Colorectal cancer is the third most common cancer 
in men and the second in women, and breast and prostate 
cancer are the leading cause of cancer death in women and 
men worldwide, respectively (Ferlay et al., 2010).
Several strategies,  including surgery, radio and 
chemotherapy have been developed to treat different types 
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of cancer. Chemotherapy has proven efficient in many cases, 
however the development of resistance and toxicity continues 
to be problems during the treatment. Therefore, it is still 
essential the identification of new agents demonstrating 
chemotherapeutic and chemopreventive activities. In this 
sense the monoterpenes have been suggested as good 
candidates for the study of antitumor agents. Shoff et al. 
(1991) demonstrated that the monoterpene geraniol increase 
the population doubling time of leukemia and melanoma 
cells. Several authors demonstrated that synthetic geraniol 
compromise growth of in vitro tumor cell lines and the wild 
variety of in vivo tumors types, including hepatoma, pancreatic 
and colon which is highly resistant to chemotherapy (Yu et al., 
1995; Burke et al., 1997; Duncan et al., 2004; Carnesecchi et al., 
2001; 2002; Ong et al., 2006; Wiseman et al., 2007). In the same 
way, the monoterpene limonene exerts therapeutic activity 
against breast, skin, liver, lung and stomach tumors in rodents 
(Elegbede et al., 1986; Wattenberg and Coccia, 1991; Crowell and 
Gould, 1994; Kawamori et al., 1996; Crowell, 1999). Additionally, 
tumor-suppressive activity has been reported to monoterpenes 
like carvone, carveol, mentol and perillyl alcohol (He et al., 1997).
Brazil has one of the richest biodiversity worldwide with 
nearly 19% of the world flora (MMA, 1998). Monoterpenes are 
found in several plant species, including species of the Lippia 
genus. Furthermore, Brazil has one of the main diversity centers 
of the genus Lippia, which is located at the Espinhaço Mountain 
Range, in the State of Minas Gerais, Brazil (Salimena-Pires 1991; 
Viccini et al., 2004). The genus Lippia belongs to the Verbenaceae 
family and comprises approximately 200 species of herbs, 
shrubs and small trees (Sanders, 2001). Several species of the 
genus Lippia are used for treatment of respiratory disorders, 
being employed as remedy for colds, grippe, bronchitis, 
coughs and asthma (Caceres et al., 1991; Forestieri et al., 1996; 
Pascual et al., 2001; Jean et al., 2012). They are also commonly 
utilized as gastrointestinal remedies and as seasoning for food 
preparation (Hennebelle et al., 2008; Oliveira et al., 2007, Pascual 
et al., 2001). Additionally, some Lippia species are used to treat 
hepatic diseases, burns, wounds, fever, syphilis, gonorrhea, 
diarrhea, dysentery, malaria, among others. (Pascual et al., 
2001). Importantly for the two best studied species of this genus, 
L. alba and L. sidoides, previous studies reported antioxidant 
activity, indicating that these plants might be a potential 
source of antitumor biomolecules (Ramos et al., 2003; Monteiro 
et al., 2007). Yet, other specie is which antioxidant activity was 
reported was L. salviifolia (Silva, 2008). The pharmacological 
properties of the Lippia species have been related to the 
components of their secondary metabolism, specifically to their 
essential oils (Pascual et al., 2001). The main constituents of 
Lippia essential oil are the monoterpenes, and according to the 
major monoterpene present in their oil they can be classified 
in different chemotypes (Pascual et al., 2001). Although several 
pharmacological studies have been performed for many Lippia 
species, very few studies were performed for the ones native to 
Brazil, such as L. lacunosa and L. rotundifolia (Jardim Botânico do 
Rio de Janeiro, 2013).
The aim of the present study was to chemically characterize 
the essential oils extracted from L. alba, L. sidoides, L. salviifolia, 
L. rotundifolia and L. lacunosa and to evaluate their effect on 
viability of tumor cell lines.
Materials and methods
Plant material
Fresh leaves were collected for each one of the Lippia species, 
Verbenaceae, L. alba (Mill.) N.E. Brown geraniol and carvone 
chemotypes, L. sidoides Cham., L. salviifollia Cham., L. rotundifolia 
Cham. and L. lacunosa Mart. and Schauer at the Experimental 
Station located on the campus of the Federal University 
of Juiz de Fora, Juiz de Fora, Brazil (21º46’48.4”S 43º22’24.4” 
W). Each one of the Lippia species was collected in the early 
morning or late afternoon, without rain, from October 2009 to 
February 2010. The voucher specimens of the Lippia species 
evaluated in this study are deposited at the CESJ Herbarium of 
Federal University of Juiz de Fora and the voucher specimens 
numbers are: L. alba geraniol chemotype: 48374, L. alba carvone 
chemotype: 48463, L. sidoides: 49007, L. salviifolia: 47444, L. 
rotundifolia: 31376 and L. lacunosa: 51920.
Essential oil extraction
The essential oils from fresh leaves of the Lippia species were 
obtained separately by hydrodistillation in a Clevenger-type 
apparatus for 4 h. The oils were measured and aliquots of 5 
mg of each one of them were stored at -80°C in sealed vials 
covered with aluminum foil until use. For each one of the 
assays described below one aliquot was defrost and dissolved 
in 4% dimethyl sulfoxide, DMSO (Sigma, St. Louis, MO, USA) 
and purified water, making up a stock solution of 1 mg/ml.
Gas chromatography/mass spectrometry analysis
The chemical composition of the essential oil of each Lippia 
specie was determined by gas chromatography coupled to 
mass spectrometry performed on a Shimadzu QP5050A GC/
MS instrument, equipped with a PTE-5 Supelco column 
(30 m × 0,25 mm × 0,25 μm). The carrier gas was helium 
(1 ml/ml). The column temperature ranged from 30° to 
250°C. The split rate was 1:20 and the injector and interface 
temperature were 250°C. The total analysis time was 
39.17 min with a flux of 19.8 ml/min. Retention indexes 
(RI) were calculated from retention times generated from 
the analysis of each oil in comparison with the standard 
n-alkanes solution, C8-C20, analyzed, and used to 
determine the components of each one of the essential oils, 
according to Adams (1995). The amount of compounds was 
determined by peaks area integration of the spectrograms.
Cell line and culture condition
Mouse colon carcinoma CT26.WT cells were provided by 
Dra. Lucíola Bastos from the Department of Physiology and 
Biophysics, Biological Sciences Institute, Federal University 
of Minas Gerais, Brazil; human lung carcinoma A549 cells 
was obtained by cell bank of Rio de Janeiro, Brazil; human 
mammary gland adenocarcinoma MDA MB-231 cells was 
provided by Dr. Ricardo R. Brentani from Ludwig Institute 
for Cancer Research, São Paulo, Brazil; human colon 
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adenocarcinoma CACO-2 cells was obtained by cell bank of 
Rio de Janeiro, Brazil and the hamster normal ovary CHO 
cells was obtained by Pan American Foot-and-Mouth Disease 
Center, Rio de Janeiro, Brazil. Each one of the cancer cell lines 
were cultured in appropriate medium at 37°C with 5% CO2. 
CT26.WT, MDA MB-231 and CHO were grown in RPMI 1640 
medium, pH 7.4 (Cultilab, Campinas, SP, Brazil) supplemented 
with 10% fetal bovine serum (FBS), 0.1 mg/ml ampicillin, 0.1 
mg/ml kanamycin, 0.005 mg/ml amphotericin, 0.2% NaHCO3 
and 0.2% HEPES (Sigma, St. Louis, MO, USA). A549 and CACO-2 
were grown in DMEM medium (Cultilab, Campinas, SP, 
Brazil) supplemented with 10% FBS, 0.1 mg/ml kanamycin, 
0.005 mg/ml amphotericin and 0.37% NaHCO3 (Sigma, St. 
Louis, MO, USA).
Cytotoxicity assay
The cytotoxicity of all six essential oils were measured 
us ing  the  MTT [3- (4 ,5-d imethyl thiazol -2-y l ) -2 ,5-
diphenyltetratozolium bromide] (Sigma, St. Louis, MO, USA) 
colorimetric assay (Denizot and Lang, 1986). Cells from each 
cell line were seeded into 96-well plates at a density of 2 × 
103 cells/well in 100 μl of appropriated medium supplemented 
with 10% FBS. After 48 h of incubation at 37°C, cells were 
treated with medium supplemented with 10% FBS containing 
different concentrations of each one of the six essential 
oils, separately. The stock solutions of each essential oil 
were diluted in four concentrations, 0.1, 1.0, 10 and 100 μg/
ml. The negative control samples contained 0.4% DMSO, 
which is equivalent to the percentage found in the highest 
concentration evaluated. The positive control samples 
contained 5-fluorouracil (5-FU), an analogue of the pyrimidine 
uracil and one of the oldest anticancer agents (Casale et al., 
2004), at four different concentrations, 0.1, 1.0, 10 and 100 μM. 
The blank control contained only RPMI medium supplemented 
with 10% FBS. After 72 h of incubation at 37°C, medium was 
discarded and 10 μl tetrazolium dye (MTT) solution (5 mg/
ml in PBS) was added to each well. Cells were incubated at 
37°C for 4 h, then the solution was discarded and 100 μl of 
dimethyl sulfoxide (DMSO) was added to dissolve the formed 
formazan crystals. The microplates were read in a TP-reader 
(Thermoplate) at 540 nm. 
Statistical analysis
At each experimental plate, all the samples were repeated 
six time and all MTT assays were performed in different 
independent experiments. The results were analyzed using 
the software GraphPad Prisma 5.0 (GraphPad Software, 
Inc.). Each treated group and the control was compared 
by Bonferroni Test and when p < 0.05 the differences were 
considered significant. Cell viability was calculated using 
the following equation: A/C × 100, where A is the arithmetic 
average of the OD of each sample and C is the arithmetic 
average of the OD observed in the negative control. The cell 
viabilities values were used to calculate the concentration 
that corresponds to 50% of cell lethality (IC50), through 
linear regression using the software Sigma Plot 10.0 (Systat 
Software, Inc.).
Results
Composition of the essential oils obtained from five Lippia species
Table 1 presents the compounds identified by gas-
chromatography followed by mass spectrometry in the 
essential oils of L. alba geraniol and carvone chemotypes, 
L. sidoides, L. salviifolia, L.rotundifolia and L. lacunosa. 
Approximately fourteen main compounds were detected, 
but to the most of them the contents were very low. For L. 
alba geraniol chemotype the compounds with the highest 
percentages were geranial and citral and to carvone 
chemotype were carvone and limonene. In the oil of L. 
sidoides the main compounds were thymol and o-cymene. 
The major constituents of L. salviifolia essential oil were 
nerolidol and germacrene D and of L. rotundifolia were 
E-myrcene and (E,Z)-, (E,E)-, and (Z,Z)-farnesol. Finally, the 
most abundant components for the essential oil of L .lacunosa 
were myrcenone and E-myrcene.
Effect of the essential oils of Lippia species on tumor cell lines 
viability
Table 2 shows the IC50 values (which are the concentrations 
that corresponds to 50% cell lethality) of cells treated with 
each one of the essential oils extracted from the Lippia 
species. It was determined that IC50 values were obtained 
only in the presence of essential oils of L. sidoides (19.05 μg/
ml), L. salviifolia (30.20 μg/ml) and L. rotundifolia (36.30 μg/
ml) on CT26.WT cell line and L. alba carvone chemotype 
essential oil (47.80 μg/ml) on A549 cell line. In the Fig. 1 we 
observe the representative curve concentration-response as a 
measurement of the OD values determined by the MTT assay. 
It illustrates the reduction of CT26.WT cell viability after 
treatment with the essential oils of L. sidoides, L. salviifolia and 
L. rotundifolia and the reduction of A549 cell line viability with 
the essential oil from L. alba carvone chemotype. On the other 
hand, MDA MB-231 and CACO-2 cell lines did not have their 
viability significantly compromised by the Lippia essential oils 
evaluated in this study (Table 2). Except for CACO-2 cell line, 
the positive control 5-FU reached IC50 levels were 7.94 μg/ml 
to CT26.WT, 8.30 μg/ml to A549 and 7.60 μg/ml to MDA MB-231 
cell lines. The essential oils of Lippia also did not compromise 
cell viability of normal cell line CHO (Table 2).
Discussion
Historically, numerous drugs have been developed 
from compounds originally isolated from medicinal plants 
(Lee, 1999). Since 1961 plant-derived compounds have 
been approved as anticancer drugs to, such as vinblastine 
(Velban), vincristine (Oncovin), etoposide (VP-16), teniposide 
(VM-26), paclitaxel (Taxol), navelbine (Vinorelbine), taxotere 
(Docetaxel), topotecan (Hycamitin) and irinotecan (Camptosar) 
(Dholwani et al., 2008). Recently, several studies have 
suggested that monoterpenes could represent a new class 
of agents to be used as anticancer drugs, which is especially 
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important for tumors highly resistant to chemotherapy and to 
minimize the side effects of the current treatments (Shoff et al., 
1991; Yu et al., 1995; Burke et al., 1997; He et al., 1997; Crowell, 
1999; Duncan et al., 2004; Wiseman et al., 2007; Chaouki et al., 
2009). Several of these monoterpenes are found in Lippia species 
and Brazil is one of the largest centers of diversity of this genus, 
comprising 70-75% of the known species (Viccini et al., 2006). In 
this study, it was initially identified the chemical compounds 
of the essential oils extracted from each one of the five Lippia 
species. GC-MS was performed and the results are shown in 
Table 1. For Lippia alba geraniol chemotype, geranial and citral 
were the major compounds, comprising approximately 63%. 
Tavares et al. (2005) obtained the same major compounds. 
For the chemotype carvone, carvone and limonene were the 
main constituents, comprising around 70% of the essential oil. 
Zoghbi et al. (1998) obtained these same components among 
the majority ones. For L. sidoides, the major compound was 
thymol (63.20%), which is in agreement with Costa et al. (2005). 
L. salviifolia had nerolidol (49.22%) being the major compound of 
its essential oil, as Singulani et al. (2012). For L. rotundifolia and 
L. lacunosa the major compounds wereE-myrcene (18.48%) and 
myrcenone (58.57%) respectively. Leitão et al. (2008) obtained 
the same ones for L. lacunosa. Therefore, these results showed 
that the major components identified in each one of the five 
species are in agreement with previous studies, and confirmed 
the identity of the Lippia chemotypes used in this study.
In order to evaluate effect of the essential oil extracted 
from Lippia species on tumor cell viability, the MTT 
assay was undertaken. According to the National Cancer 
Institute (USA), vegetables crude extracts are cytotoxic 
considered when their IC50 values are less than 30 μg/ml 
(Hennebelle et al., 2008; Mesa-Arango et al., 2009). This 
assay showed that 50% of cell inhibition was obtained 
with concentrations under or near to 30 μg/ml for CT26.
WT with the essential oils of L. sidoides (19.05 μg/ml) and 
L. salviifolia (30.20 μg/ml) (Fig. 1 and Table 2). The growth 
suppression effect of thymol, the major compound of L. 
sidoides essential oil, has been reported through IC50 value 
on the B16F10 mouse melanoma cell line (He et al., 1997). 
Nerolidol, the major compound of L. salviifolia essential oil, 
had been previously also demonstrated antiproliferative 
action on human leukemia HL-60. (Tatman and Mo, 2002). 
The IC50 values obtained for A549 cells treated with L. alba 
carvone chemotype essential oil (47.80 μg/ml) and CT26.
WT cell treated with L. rotundifolia essential oil (36.30 μg/
ml) (Fig. 1 and Table 2) did not classify them as cytotoxic 
crude extracts by the National Cancer Institute. Besides 
the selectivity on colon tumor cell line, it was not observed 
Compounds RIa L. alba geraniol L. alba carvone L. sidoides L. salviifolia L. rotundifolia L. lacunosa
sabinense 976 0.72 1.62 - 0.79 0.80 -
E-pinene 980 - - - 1.24 1.88 -
E-myrcene 991 0.50 - 2.14 - 18.48 19.47
D-phellandrene 1005 - - - - 4.44 -
D-terpinene 1018 - - 0.91 - - -
o-cymene 1022 1.95 - 10.89 - 0.62 -
E-phellandrene 1031 - - - - 2.21 -
limonene 1031 9.62 21.34 - 0.99 - 1.21
(E)-E-ocimene 1050 - - - - 0.45 -
J-terpinene 1062 4.23 - 4.61 - - -
linalool 1098 1.07 1.43 3.14 0.83 1.03 0.96
myrtenol 1194 - - - - 1.13 -
myrcenone 1148 - - - - - 58.57
terpinen-4-ol 1177 - - 0.41 - - -
D-terpineol 1189 - - - - - 0.53
verbenone 1204 - - - - - -
nerol 1228 0.62 - - - - -
Table 1
Percentage chemical composition of the compounds of the essential oils extracted from leaves of L. alba geraniol and carvone 
chemotypes, L. sidoides, L. salviifolia, L. rotundifolia and L. lacunosa, as determined by gas-chromatography followed by mass 
spectrometry. The high content compounds were highlighted.
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Compounds RIa L. alba geraniol L. alba carvona L. sidoides L. salviifolia L. rotundifolia L. lacunosa
(Z)-ocimenone 1231 - - - - - 3.60
thymol methyl ether 1235 - - 3.82 - - -
(E)-ocimenone 1239 - - - - - 4.60
citral 1240 26.13 - - - - -
carvone 1242 - 48.35 - - - -
geraniale 1270 36.53 - - - - -
thymol 1290 - - 63.20 - - -
carvacrol 1298 - - 3.46 - - -
D-copaene 1376 - - - 1.72 - -
E-bourbonene 1384 - 0.74 - - - -
geranyl acetate 1383 - - - - - 1.12
E-elemene 1391 0.67 0.90 - 4.03 3.45 -
(E)-caryophyllene 1418 - - 0.53 7.06 3.68 3.89
D-humulene 1454 - - 5.06 1.48 0.66 0.57
9-epi-(E)-caryophyllene 1467 - - - 0.91 - -
J-muurolene 1477 4.72 - - - - -
germacrene D 1480 - 7.91 - 18.30 - 0.71
ar-curcumene 1483 - - - - 2.87 -
bicyclogermacrene 1494 - - - 3.11 - -
D-zingiberene 1495 0.69 - - - 1.93 -
D-chamigrene 1500 - - - - 2.65 -
E-curcumene 1512 - - - - 4.13 -
J-cadinene 1513 0.55 0.56 - - - -
G-cadinene 1524 - - - 1.52 - -
elemol 1549 8.24 10.66 - - 3.66 -
nerolidol 1564 0.73 1.03 - 49.22 - -
espatulenol 1576 - - - 0.91 2.05 -
caryophyllene oxide 1581 - - - 0.88 2.02 1.73
guaiol 1595 0.83 1.10 - - - -
J-eudesmol 1630 - 0.64 - - 0.57 -
D-eudesmol 1652 - - - - 0.72 -
D-cadinol 1653 - - - 1.35 - -
7-epi-D-eudesmol 1658 - 0.71 - - - -
epi-D-bisabolol 1686 - - - 1.73 - -
(Z,Z)-farnesol 1713 - - - - 10.60 -
(E,E)-farnesol 1722 - - - - 10.91 -
(E,Z)-farnesol 1742 - - - - 16.47 1.67
TOTAL  97.80 96.99 98.17 96.07 97.41 98.63
a RI, Retention index.
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Figure 1 - The cytotoxic effect, as a measurement of the OD values determined by the MTT assay, of the different 
concentrations (0.1-100 μg/ml) of L. sidoides, L. salviifolia and L. rotundifolia essential oils on CT26.WT cell line (A) and L. alba 
carvone chemotype essential oil on A549 cell line (B). The control samples contained 0.4% DMSO, which is equivalent to the 
percentage found in the highest concentration evaluated. * p < 0.05. ** p < 0.01. *** p < 0.001 are significantly different from the 
control value.
Cell lines L. alba geraniol L. alba carvone L. sidoides L. salviifolia L. rotundifolia L. lacunosa 5-FU
Tumor
CT26.WT - - 19.05 30.20 36.30 - 7.94
A549 - 47.80 - - - - 8.30
MDA MB-231 - - - - - - 7.60
CACO-2 - - - - - - -
Normal CHO - - - - - - 79.40
toxic effect in normal cell (CHO) exposed to each one of the 
essential oil tested. 
In conclusion the present results showed a significant 
cytotoxic effect of L. sidoides and L. salviifolia essential oils on 
CT26.WT colon tumor cells which might be attributed to their 
major compounds. Also importantly it showed the absence 
of this effect on the normal cell line. Therefore, these finds 
stimulates further studies on their mechanisms of action in 
order to be considered for in vivo studies.
Table 2
IC50 values (μg/ml) of cell lines treated for 72 h with the four different concentrations, 0.1, 1, 10 and 100 μg/ml of each one of 
the essential oils extracted from the Lippia species. The negative control samples contained 0.4% DMSO, which is equivalent 
to the percentage found in the highest concentration evaluated. The positive control samples contained 5-FU at four different 
concentrations, 0.1, 1, 10 and 100 μM.
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